Fingerprint
Dive into the research topics of 'Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab
David J. Jackson, Stephanie Korn, Sameer K. Mathur, Peter Barker, Venkata G. Meka, Ubaldo J. Martin, James G. Zangrilli*
*Corresponding author for this work
Research output: Contribution to journal › Review article › peer-review
59
Citations
(Scopus)